The Effect of Nefopam on Catheter-related Bladder Discomfort

Seoul National University Hospital110 enrolled

Overview

In the present study, the investigators evaluated whether nefopam 20 mg reduce the catheter-related bladder discomfort in patients undergoing foley catheter insertion

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

110

Conditions

Nefopam Catheter-related Bladder Discomfort

Interventions

Nefopam or salineDRUG

One hour before the end of the operation, the Nefopam group was received 20 mg of nefopam and the saline and the control group was received 20 ml of saline.

Eligibility

Sex: MALEMin age: 20 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients scheduled to insert the catheter a new foley catheter more than 14 Fr in the operation site, 2. Adults 20 to 75years of age 3. American Society of Anesthesiologists Physical Classification 1,2 patients 4. Patients who pre-agreed to the study 5. Male patient Exclusion Criteria: 1. Neurogenic bladder 2. Patients diagnosed with irritable bladder 3. study drug sensitive or contraindicated 4. Patients with central nervous system or neurological disorder (epilepsy, patients receiving MAO inhibitor) 5. Patients with urethral and prostate disorders 6. Patients with previous history of myocardial infarction 7. Patients with closed angle glaucoma

Locations (1)

Seoul National Univ. Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea

Outcomes

Primary Outcomes

catheter-related bladder discomfort

assessment of catheter-related bladder discomfort using visual analogue scale

Time frame: postoperative 1 hour

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.